Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: ropivacaine: 4 mL of 0.2% preservative-free ropivacaine sprayed via MADGIC atomizer during laryngoscopy before intubation and is sprayed over the oropharynx, glottis, and upper trachea.
Sponsors
All India Institute Of Medical Sciences Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 18 to 65 years 2.ASA Physical Status I to III 3.Scheduled for elective robotic surgery under 4.general anesthesia with ETT 5.Provided written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patient who refuses to participate in thestudy 2.Known allergy to local anaesthetics 3.Upper respiratory infection in the past two weeks 4.Difficult intubation or more then 2 attempts 5.Pre-existing sore throat, hoarseness, or vocal cord pathology 6.Anticipated difficult airway 7.Surgery more than 5 hours 8.Any patient who requires prolonged mechanical ventilation (more than 5 hours) will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of post operative sore throat postoperatively in patients undergoing elective robotic surgery under general anesthesiaTimepoint: first 2 hrs after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the severity of post operative sore throat at 6, 12, and 24 hours post-extubation using a standardized 4-point grading scale. To evaluate the incidence of associated symptoms such as hoarseness and coughing. To assess patient-reported satisfaction regarding throat comfort postoperatively. To monitor for any local or systemic adverse effects related to topical ropivacaine useTimepoint: first 24 hrs after surgery | — |
Countries
India
Contacts
Public ContactDr Aman Balwada
All India Institute Of Medical Sciences Jodhpur
Outcome results
None listed